tirzepatide surmount-1 percent weight loss 72 weeks after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Results were over 72 weeks.
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19























